SEC Filing Summary

This filing is a Form 4, which reports a transaction by Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. On September 4, 2026, Mr. Simmons acquired 115.3849 deferred stock units, with a transaction value of $24.50 per unit. These units are convertible into shares of the company's common stock. Following this transaction, Mr. Simmons holds 25,245.5086 deferred stock units. The deferred stock units will settle in cash or shares of the company's common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan. Each unit represents the right to receive one share of Company common stock or its cash equivalent.